What is Voxel?
Voxel operates as a wholly-owned subsidiary of Holorad, a privately held entity based in Salt Lake City, Utah. The Voxel team possesses deep expertise in medical business development, encompassing mergers and acquisitions, venture capital, and both private and public equity. Their consulting cadre further enhances this with specialized knowledge in medical imaging, medical device manufacturing, quality assurance and regulatory affairs (QA/RA), and sales and marketing, positioning Voxel as a comprehensive player in its sector.
How much funding has Voxel raised?
Voxel has raised a total of $1.6M across 1 funding round:
Angel/Seed
$1.6M
Angel/Seed (2013): $1.6M with participation from Sherpalo, Pinnacle Ventures, and First Round Capital
Key Investors in Voxel
Sherpalo
Sherpalo Ventures is an early-stage investment firm that collaborates with visionary founders to create transformative companies. The firm offers capital, expertise, and a supportive network to assist in the journey from seed to success. Their investment focus includes sectors such as Artificial Intelligence, Enterprise, Consumer Internet, and Internet Security. Sherpalo Ventures aims to partner with innovative companies that are shaping the future.
Pinnacle Ventures
Pinnacle Ventures is dedicated to partnering with passionate entrepreneurs to help them build category-leading companies. With nearly two decades of experience, they offer a broad range of flexible growth capital options. Their experienced team collaborates closely with clients, leveraging an extensive network to provide valuable support. Pinnacle Ventures focuses on innovation and aims to deliver value beyond traditional investment.
First Round Capital
First Round Capital is a prominent venture capital firm known for its early-stage investments in technology companies. They focus on building deep relationships with founders, providing not just capital but also strategic guidance and operational support to help startups scale effectively. Their investment thesis often centers on disruptive technologies and innovative business models across various sectors.
What's next for Voxel?
The substantial enterprise-level funding Voxel has attracted, particularly the recent strategic investment, indicates a strong market validation and provides the necessary resources for accelerated expansion. This capital infusion is expected to fuel advancements in their core business areas, potentially leading to new product development, market penetration, and strategic partnerships. The company's focus on medical business development, combined with its specialized consulting experience, suggests a trajectory aimed at significant impact within the medical technology and imaging industries.
See full Voxel company page
